Antibiotic Resistance Market To Reach $14.26 Billion By 2033

May 2026 | Report Format: Electronic (PDF)

Antibiotic Resistance Market Growth & Trends

The global antibiotic resistance market size is expected to reach USD 14.26 billion by 2033, registering a CAGR of 4.98% from 2026 to 2033, according to a new report by Grand View Research, Inc. Rise in the number of antibiotic-resistant infections due to misuse or overuse of antibiotics is a major factor attributing to market growth. Moreover, the increasing patient base across the globe and high costs associated with the treatment of diseases is anticipated to boost the market growth over the forecast period.

The prevalence of gram-negative infections is increasing at an alarming rate. These infections have lesser treatment options available in the market. The high unmet needs result in high demand for new therapies and, therefore, small and medium-sized pharmaceutical companies are actively involved in the development of novel treatment options. Moreover, the government and other organizations are also aiding research activities to drive the development of innovative therapies.

Multiple mid-level biotechnology companies have entered the arena with targeted therapies for antibiotic-resistant infections. Various manufacturers are developing therapies, especially for drug-resistant infections, that target a smaller population subset.

The U.S. government in alliance with BARDA is supporting several companies to boost the development of new therapies for antibiotic-resistant diseases. BARDA has also been associated with pharmaceutical companies such as GSK; Tetraphase; Basilea; Astra Zeneca; and many more. Many countries and international organizations have formed dedicated groups or alliances to monitor and study the pattern of drug-resistant infections.

For instance, the WHO has introduced the Global Antimicrobial Resistance Surveillance System (GLASS) to monitor antibiotic-resistant infections at a global level. Similarly, the Public Health Agency of Canada has introduced the Canadian Antimicrobial Resistance Surveillance System (CARSS) to study drug-resistant infections pattern at the country level.

However, according to a review published by WHO in March 2023, the antibiotics pipeline activities are limited, with only 12 new antibiotics being approved between 2017 and 2021. The review further stated that there are only 27 new candidates under development, out of which only 6 are considered “innovative” enough to be capable of overcoming antibiotic resistance as defined by WHO.

key Request a free sample copy or view report summary: Antibiotic Resistance Market Report

Antibiotic Resistance Market Report Highlights

The cUTI segment dominated the antibiotic resistance market, accounting for the largest revenue share of 23.70% in 2025, due to the increasing prevalence of multidrug-resistant urinary tract infections caused by pathogens such as E. coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.
The K. pneumoniae segment dominated the antibiotic resistance industry, accounting for the largest revenue share of 20.59% in 2025, due to the rising prevalence of multidrug-resistant and carbapenem-resistant strains across healthcare settings.
The oxazolidinones segment dominated the market, accounting for a significant revenue share in 2025, driven by the rising prevalence of multidrug-resistant Gram-positive bacterial infections.
The cell wall synthesis inhibitors segment dominated the antibiotic resistance industry with the largest revenue share of 50.96% in 2025, driven by the persistent global burden of bacterial infections and the rising prevalence of antimicrobial resistance.
The hospital pharmacies segment dominated the antibiotic resistance market with the largest revenue share of 51.11% in 2025, driven by the high burden of severe and multidrug-resistant infections requiring controlled clinical management.
The North America antibiotic resistance market held the largest share of 36.47% in 2025, driven by the high burden of antimicrobial-resistant infections and advanced healthcare infrastructure.

Antibiotic Resistance Market Segmentation

Grand View Research has segmented the global antibiotic resistance market on the basis of disease, pathogen, mechanism of action, drug class, distribution channel, and region:

Antibiotic Resistance Disease Outlook (Revenue, USD Million, 2021 - 2033)